MondayOct 03, 2011 10:59 am

NeoStem, Inc. (NBS) Subsidiary Progenitor Cell Therapy Secures Key Brain Cancer Vaccine Manufacturing Agreement with ImmunoCellular Therapeutics

NeoStem, an extremely well-positioned leader in the cell therapy space, via wholly-owned subsidiary Progenitor Cell Therapy, LLC, recently announced a major manufacturing agreement with clinical-stage biotech firm ImmunoCellular Therapeutics, Ltd., a developer of innovative immune-based therapies for brain and other cancers. Progenitor will serve a key manufacturing role in production during the run up to Phase II clinical trials of ICT-107, obtaining a strong foothold for as a strategic partner for a future Phase III involving the powerful new glioblastoma vaccine, which utilizes a dendritic cell-based targeting of a host of antigens linked to such tumors. President and CSO of…

Continue Reading

MondayOct 03, 2011 10:41 am

LML Patent Corp. (LMLP) Video Chart for Monday, October 3, 2011

In a classic bounce position, LMLP made a solid move on Friday, but gave a fair amount of the gains back by the end of the day. Technical traders will be watching for momentum to come into the play to start this week as resistance is still nearly 40 cents away. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Continue Reading

MondayOct 03, 2011 9:24 am

Zhongpin, Inc. (HOGS) Starts Trial Production of Prepared Pork Products at New Plant in Tianjin

Zhongpin, Inc., a meat and food processing company that specializes in pork and pork products in the People's Republic of China, announced that it has started trial production at its new prepared pork products plant in Tianjin. The plant cost about $22 million and will produce about 36,000 metric tons annually. Zhongpin will produce sausages, hotdogs and other low-temperature meat products at the new prepared pork facility. Zhongpin reports that this is phase 2 of its industrial park in Tianjin. Phase 1 is the chilled and frozen pork plant that has produced about 100,000 metric tons yearly since it opened…

Continue Reading

MondayOct 03, 2011 8:57 am

American Standard Energy Corp. (ASEN) Issues Oil and Gas Operational Update

American Standard Energy issued an operational update on the company’s oil and gas activities in the United States. The company is active in various producing basins in North Dakota and Texas. American Standard Energy recently initiated a twenty six well drilling program in the Permian Basin in Texas. The company is operating three rigs here and is targeting the Wolfberry and Wolfcamp formations in three different counties. American Standard Energy is waiting for the initial production rates of two wells that were recently completed and has five additional wells scheduled for hydraulic fracturing operations. The company is also attempting to…

Continue Reading

MondayOct 03, 2011 8:13 am

Small Cap Voice: Medical Alarm Concepts (MDHI) Receives Growth Capital Injection and Commitment for Future Funding

Medical Alarm Concepts Holding, Inc. recently announced it has received a new commitment for capital that will be used to accelerate corporate growth and advance marketing programs for the MediPendant™, the first fully-monitored medical alarm system that allows users to speak and listen directly through the pendant. Approximately one third of this private investment group funding has already been received. The remaining portion will be invested into the operation over the next few months. “We have always known that our patented product would change the future of the large and growing Personal Emergency Response System (PERS) market, but funding our…

Continue Reading

MondayOct 03, 2011 8:11 am

eLayaway, Inc. (ELAY) Spammed Aggressively over Weekend

We have observed an influx of emails spamming eLayaway, Inc. from various free email accounts over the weekend. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page,…

Continue Reading

FridaySep 30, 2011 5:05 pm

Strategic American Oil Corp. (SGCA) is “One to Watch”

Strategic American Oil Corp. is an oil and natural gas exploration and production company with operations in Texas, Louisiana, and Illinois. Leveraging its technical expertise, promising portfolio and strong financial condition, the company is in an advantageous position to experience remarkable growth in the near term future by aggressively leasing, drilling, and acquiring projects at various stages of development. To date, Strategic American Oil has established a land portfolio with an aggregate gross 5,236 developed and undeveloped acres in Texas and Illinois alone. With this acreage, the company has identified new exploration targets and is applying advanced technology to maximize…

Continue Reading

FridaySep 30, 2011 3:30 pm

Threshold Pharmaceuticals, Inc. (THLD) Announces Initiation of Phase 3 TH-302 Combination Trial for Patients with Advanced Tissue Sarcoma

Threshold Pharmaceuticals, Inc., in partnership with Sarcoma Alliance for Research through Collaboration (SARC), has announced the initiation of a Phase 3 randomized clinical trial of TH-302 in patients with soft tissue sarcoma. This pivotal international trial will enroll patients with metastatic or locally advanced unrespectable soft tissue sarcoma who have not received chemotherapy other then the adjuvant or neoadjuvant setting. The trial has been designed to evaluate the capability and the safety of TH-302 in combination with doxorubicin, in comparison to just doxorubicin alone. Succeeding an end of Phase 2 meeting with the FDA, the Phase 3 protocol has been…

Continue Reading

FridaySep 30, 2011 3:27 pm

Intellect Neurosciences (ILNS), ViroPharma (VPHM) Ink Licensing Agreement

Intellect Neurosciences Inc. today announced it has granted an exclusive license to ViroPharma Inc., in which the company will receive licensed patents and patent applications related to Intellect's orally administered, clinical stage drug candidate, OX1. ViroPharma plans to develop and commercialize OX1 to treat Friedreich's Ataxia, a disease that causes nervous system damages and affects movement, as well as for the treatment of diseases for which OX1 may qualify for orphan drug designation. "We are pleased to enter into a strategic relationship with ViroPharma, which has ample resources, drug development capabilities and orphan drug marketing expertise to accelerate the development…

Continue Reading

FridaySep 30, 2011 2:49 pm

BeaconEquity.com: DoJ Investigation of 9 Chinese Companies triggers Sell-off

Chinese companies trading on North American exchanges are once again in the regulatory spotlight; this time, it’s the Chinese Internet companies that are under fire. According to reports, the U.S. Justice Department (DoJ) is investigating possible accounting frauds at a number of Chinese Internet companies trading on U.S. exchanges, which isn’t too much of a surprise considering swelling speculation regarding the legitimacy of Chinese stocks. Keep your eye on these guys and trade at your own risk: SINA Corp. (NASDAQ: SINA), Baidu.com Inc. (ADR) (NASDAQ: BIDU), Yoku.com Inc. (NYSE: YOKU), Focus Media (NASDAQ: FMCN), Sohu.com Inc. (NASDAQ: SOHU), Ctrip.com (NASDAQ:…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered